Friday 14 February 2020

Diet Drug Belviq Withdrawn Due to Cancer Risk

overweight woman in gym

The FDA asked the maker of weight-loss drug Belviq (lorcaserin) to take it off the market after a clinical trial showed an association with an increased risk of cancer.



from WebMD Health https://ift.tt/2SrsAgb

0 comments:

Post a Comment